Pharmaceutical innovation in Europe, a call to action by Arthur Higgins - EFPIA president

In a recent conference in Portugal the EFPIA president adressed innovation issues in Europe and called for action on four areas, such as better patient access to new discoveries whereby Health Technology Assessment should not be used as a means of restricting access to new medicines, fair reward for innovation - including incremental innovation, strong intellectual property protection and new thinking to balance healthcare costs - shift away from the cost of medicines to their value.